ArticlePLoS biology2025
Linking citation and retraction data reveals the demographics of scientific retractions among highly cited authors.
Article in PLoS biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- National-, institutional-, and individual-level determinants of dental research excellence: an analysis of Stanford-Elsevier lists of the top 2% scholars worldwide (2017-2023).Frontiers in oral health · 2025Pooled it
- Cost of Retracted Articles to the NIH: a Living Analysis.medRxiv : the preprint server for health sciences · 2026Article
- The Challenges of Scientific Publishing: An Editor-In-Chief's Perspective.Fundamental & clinical pharmacology · 2026Article
- Retractions in tuberculosis research: analyzing patterns, reasons, and temporal trends from 1993 to 2023.Archives of microbiology · 2026Article
- AI-readiness Criteria for Biomedical Data.bioRxiv : the preprint server for biology · 2026Article
- National-, Institutional-, and Individual-Level Determinants of Neurology and Neurosurgery Research Excellence: An Analysis of Stanford-Elsevier Lists of the Top 2% Scholars Worldwide (2017-2023).Neuroepidemiology · 2026Review
- Retracted Randomized Clinical Trials From Superretractors and Top-Cited Scientists With Multiple Retractions.JAMA network open · 2026Article
- Analysis of Retracted Publications in the Diabetes Literature.Medical journal of the Islamic Republic of Iran · 2026Article
- Research "junkification" is caused by researchers, not journals.Frontiers in psychology · 2026Article
- Artificial intelligence to enhance research integrity in evidence-based medicine: toward scalable trustworthiness assessment.Frontiers in research metrics and analytics · 2026Article
- In conversation with Dr. John P. Ioannidis: On meta-research, metrics, gaming, and top 2 per cent scientists.The Indian journal of medical research · 2025Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retractions are becoming increasingly common but still account for a small minority of published papers. It would be useful to generate databases where the presence of retractions can be linked to impact metrics of each scientist. We have thus incorporated retraction data in an updated Scopus-based database of highly cited scientists (top 2% in each scientific subfield according to a composite citation indicator). Using data from the Retraction Watch database (RWDB), retraction records were linked to Scopus citation data. Of 55,237 items in RWDB as of August 15, 2024, we excluded non-retractions, retractions clearly not due to any author error, retractions where the paper had been republished, and items not linkable to Scopus records. Eventually, 39,468 eligible retractions were linked to Scopus. Among 217,097 top-cited scientists in career-long impact and 223,152 in single recent year (2023) impact, 7,083 (3.3%) and 8,747 (4.0%), respectively, had at least 1 retraction. Scientists with retracted publications had younger publication age, higher self-citation rates, and larger publication volume than those without any retracted publications. Retractions were more common in the life sciences and rare or nonexistent in several other disciplines. In several developing countries, very high proportions of top-cited scientists had retractions (highest in Senegal (66.7%), Ecuador (28.6%), and Pakistan (27.8%) in career-long citation impact lists). Variability in retraction rates across fields and countries suggests differences in research practices, scrutiny, and ease of retraction. Addition of retraction data enhances the granularity of top-cited scientists' profiles, aiding in responsible research evaluation. However, caution is needed when interpreting retractions, as they do not always signify misconduct; further analysis on a case-by-case basis is essential. The database should hopefully provide a resource for meta-research and deeper insights into scientific practices.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.